All News

Frustrated by old-fashioned publishing practices, scientists are launching start-ups to change the way research is evaluated and communicated, tapping open-access platforms to increase the visibility and discoverability of their work

Start-up companies from South Africa and Nigeria selected as finalists to compete in The Global Innovation Award on 7 October in Berlin.

The big guns of European science have hit back at calls for the position of chief scientist to be scrapped. Jean-Claude Juncker, President-elect of the European Commission, hints the role may be restructured

£10M initiative to test computer-controlled vehicles in three cities

Investment from angels is on the rise, but they need help to invest wisely. It’s time to professionalise angel investing, says Herwig Rollett, co-founder of the Business Angel Institute in Vienna

In what may become the biggest paradigm shift in the history of science, Big Data is overthrowing the established scientific method

The role of the European Commission’s top science adviser is unaccountable, opaque and controversial, say lobby groups in an open letter

European Commission defends €1.2B project’s ability to set its own research scope but will examine the management structure

European Commission sets energy efficiency target of 30 per cent for 2030, in a bid to encourage investment in new technologies and increase energy security

European Commission also unveils new venture capital fund, cash R&D prizes and a new initiative to hasten promising ideas to market

Cell therapies hold the promise of more effective treatments for a range of diseases, but they face a long and expensive route to market. The key is to reduce risk and attract investors, says Keith Thompson, head of the UK Cell Therapy Catapult

MEPs voice strong reservations on the Transatlantic Trade and Investment Partnership negotiations to the EU Commissioner for Trade

Temporary stand-in Ferdinando Nelli Feroci is quizzed on his priorities for the next four months

Diabetes, hydrogen-powered vehicles and electronics are among the diverse range of research to receive funding

The uncertainty sparked by the US ruling that the BRCA1 and BRCA2 breast cancer genes are not patentable is holding back the development of diagnostics and therapies, says patent lawyer Adrian Tombling